<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03991364</url>
  </required_header>
  <id_info>
    <org_study_id>NRC-2019-01-002</org_study_id>
    <nct_id>NCT03991364</nct_id>
  </id_info>
  <brief_title>Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke</brief_title>
  <official_title>Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Rehabilitation Center, Seoul, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Rehabilitation Center, Seoul, Korea</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the experimental group that applied the speed of the robot-assisted gait
      training constantly and the control group that applied the gradual increase of the speed of
      the robot-assisted gait training.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy expenditure (EE)</measure>
    <time_frame>2 weeks after baseline</time_frame>
    <description>EE(kcal/min): energy expenditure per minute</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure (EE)</measure>
    <time_frame>baseline, 1 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>EE(kcal/min): energy expenditure per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate (HR)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>Cardiac frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Oxygen (VO2)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>O2 consumption/1min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Quotient (R)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>Respiratory quotient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic equivalent (METS)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>the amount of oxygen consumed while sitting at rest and is equal to 3.5 ml O2 per kg body weight x min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxygenated hemoglobin (OxyHb)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>oxygenated hemoglobin concentration of cortical activation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>deoxygenated hemoglobin (DeoxyHb)</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>deoxygenated hemoglobin concentration of cortical activation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower extremity Fugl-Meyer Assessment</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Ambulation Category</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10m walk test</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>timed up and go test</measure>
    <time_frame>baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline</time_frame>
    <description>simple test used to assess a person's mobility and requires both static and dynamic balance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Constant gait speed group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>experimental group that applied the speed of the robot-assisted gait training constantly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Increasing gait speed group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>control group that applied the gradual increase of the speed of the robot-assisted gait training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Constant gait speed group</intervention_name>
    <description>The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.</description>
    <arm_group_label>Constant gait speed group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Increasing gait speed group</intervention_name>
    <description>The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.</description>
    <arm_group_label>Increasing gait speed group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemiplegic patients secondary to first cerebrovascular accidents

          -  Functional ambulation category score â‰¥ 3

        Exclusion Criteria:

          -  History of surgery of affected lower limb

          -  Fracture of affected lower limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon-Ho Shin, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Rehabilitation Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joon-Ho Shin, MS</last_name>
    <phone>82-2-901-1884</phone>
    <email>asfreelyas@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Rehabilitation Center</name>
      <address>
        <city>Seoul</city>
        <zip>142884</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Rehabilitation Center, Seoul, Korea</investigator_affiliation>
    <investigator_full_name>Joon-Ho Shin</investigator_full_name>
    <investigator_title>Team manager</investigator_title>
  </responsible_party>
  <keyword>Robot-assisted gait training</keyword>
  <keyword>stroke</keyword>
  <keyword>gait speed</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

